Request for Covid-19 Impact Assessment of this Report
The United States Oncology Therapeutic Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Oncology Therapeutic Drug market, reaching US$ million by the year 2028. As for the Europe Oncology Therapeutic Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Oncology Therapeutic Drug players cover AbbVie, Amgen, Astellas Pharma, and AstraZeneca, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oncology Therapeutic Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory and Lung Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AbbVie
Amgen
Astellas Pharma
AstraZeneca
Bayer
Biogen
Bristol Myers Squibb
Celgene
Eisai
Eli Lilly and Company
Gilead Sciences
Ipsen
Johnson and Johnson
Merck
Novartis
Otsuka Pharmaceutical
Pfizer
F. Hoffmann-La Roche
Sanofi
Takeda Pharmaceutical
Teva Pharmaceutical Industries
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncology Therapeutic Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oncology Therapeutic Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oncology Therapeutic Drug by Country/Region, 2017, 2022 & 2028
2.2 Oncology Therapeutic Drug Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy
2.2.4 Hormonal Therapy
2.2.5 Others
2.3 Oncology Therapeutic Drug Sales by Type
2.3.1 Global Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Oncology Therapeutic Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oncology Therapeutic Drug Sale Price by Type (2017-2022)
2.4 Oncology Therapeutic Drug Segment by Application
2.4.1 Breast Cancer
2.4.2 Gastrointestinal Cancer
2.4.3 Prostate Cancer
2.4.4 Respiratory and Lung Cancer
2.4.5 Others
2.5 Oncology Therapeutic Drug Sales by Application
2.5.1 Global Oncology Therapeutic Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Oncology Therapeutic Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oncology Therapeutic Drug Sale Price by Application (2017-2022)
3 Global Oncology Therapeutic Drug by Company
3.1 Global Oncology Therapeutic Drug Breakdown Data by Company
3.1.1 Global Oncology Therapeutic Drug Annual Sales by Company (2020-2022)
3.1.2 Global Oncology Therapeutic Drug Sales Market Share by Company (2020-2022)
3.2 Global Oncology Therapeutic Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Oncology Therapeutic Drug Revenue by Company (2020-2022)
3.2.2 Global Oncology Therapeutic Drug Revenue Market Share by Company (2020-2022)
3.3 Global Oncology Therapeutic Drug Sale Price by Company
3.4 Key Manufacturers Oncology Therapeutic Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oncology Therapeutic Drug Product Location Distribution
3.4.2 Players Oncology Therapeutic Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oncology Therapeutic Drug by Geographic Region
4.1 World Historic Oncology Therapeutic Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Oncology Therapeutic Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oncology Therapeutic Drug Annual Revenue by Geographic Region
4.2 World Historic Oncology Therapeutic Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Oncology Therapeutic Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oncology Therapeutic Drug Annual Revenue by Country/Region
4.3 Americas Oncology Therapeutic Drug Sales Growth
4.4 APAC Oncology Therapeutic Drug Sales Growth
4.5 Europe Oncology Therapeutic Drug Sales Growth
4.6 Middle East & Africa Oncology Therapeutic Drug Sales Growth
5 Americas
5.1 Americas Oncology Therapeutic Drug Sales by Country
5.1.1 Americas Oncology Therapeutic Drug Sales by Country (2017-2022)
5.1.2 Americas Oncology Therapeutic Drug Revenue by Country (2017-2022)
5.2 Americas Oncology Therapeutic Drug Sales by Type
5.3 Americas Oncology Therapeutic Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Therapeutic Drug Sales by Region
6.1.1 APAC Oncology Therapeutic Drug Sales by Region (2017-2022)
6.1.2 APAC Oncology Therapeutic Drug Revenue by Region (2017-2022)
6.2 APAC Oncology Therapeutic Drug Sales by Type
6.3 APAC Oncology Therapeutic Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oncology Therapeutic Drug by Country
7.1.1 Europe Oncology Therapeutic Drug Sales by Country (2017-2022)
7.1.2 Europe Oncology Therapeutic Drug Revenue by Country (2017-2022)
7.2 Europe Oncology Therapeutic Drug Sales by Type
7.3 Europe Oncology Therapeutic Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oncology Therapeutic Drug by Country
8.1.1 Middle East & Africa Oncology Therapeutic Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oncology Therapeutic Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Oncology Therapeutic Drug Sales by Type
8.3 Middle East & Africa Oncology Therapeutic Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oncology Therapeutic Drug
10.3 Manufacturing Process Analysis of Oncology Therapeutic Drug
10.4 Industry Chain Structure of Oncology Therapeutic Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oncology Therapeutic Drug Distributors
11.3 Oncology Therapeutic Drug Customer
12 World Forecast Review for Oncology Therapeutic Drug by Geographic Region
12.1 Global Oncology Therapeutic Drug Market Size Forecast by Region
12.1.1 Global Oncology Therapeutic Drug Forecast by Region (2023-2028)
12.1.2 Global Oncology Therapeutic Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oncology Therapeutic Drug Forecast by Type
12.7 Global Oncology Therapeutic Drug Forecast by Application
13 Key Players Analysis
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Oncology Therapeutic Drug Product Offered
13.1.3 AbbVie Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Oncology Therapeutic Drug Product Offered
13.2.3 Amgen Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Astellas Pharma
13.3.1 Astellas Pharma Company Information
13.3.2 Astellas Pharma Oncology Therapeutic Drug Product Offered
13.3.3 Astellas Pharma Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Astellas Pharma Main Business Overview
13.3.5 Astellas Pharma Latest Developments
13.4 AstraZeneca
13.4.1 AstraZeneca Company Information
13.4.2 AstraZeneca Oncology Therapeutic Drug Product Offered
13.4.3 AstraZeneca Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 AstraZeneca Main Business Overview
13.4.5 AstraZeneca Latest Developments
13.5 Bayer
13.5.1 Bayer Company Information
13.5.2 Bayer Oncology Therapeutic Drug Product Offered
13.5.3 Bayer Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bayer Main Business Overview
13.5.5 Bayer Latest Developments
13.6 Biogen
13.6.1 Biogen Company Information
13.6.2 Biogen Oncology Therapeutic Drug Product Offered
13.6.3 Biogen Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Biogen Main Business Overview
13.6.5 Biogen Latest Developments
13.7 Bristol Myers Squibb
13.7.1 Bristol Myers Squibb Company Information
13.7.2 Bristol Myers Squibb Oncology Therapeutic Drug Product Offered
13.7.3 Bristol Myers Squibb Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Bristol Myers Squibb Main Business Overview
13.7.5 Bristol Myers Squibb Latest Developments
13.8 Celgene
13.8.1 Celgene Company Information
13.8.2 Celgene Oncology Therapeutic Drug Product Offered
13.8.3 Celgene Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Celgene Main Business Overview
13.8.5 Celgene Latest Developments
13.9 Eisai
13.9.1 Eisai Company Information
13.9.2 Eisai Oncology Therapeutic Drug Product Offered
13.9.3 Eisai Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Eisai Main Business Overview
13.9.5 Eisai Latest Developments
13.10 Eli Lilly and Company
13.10.1 Eli Lilly and Company Company Information
13.10.2 Eli Lilly and Company Oncology Therapeutic Drug Product Offered
13.10.3 Eli Lilly and Company Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Eli Lilly and Company Main Business Overview
13.10.5 Eli Lilly and Company Latest Developments
13.11 Gilead Sciences
13.11.1 Gilead Sciences Company Information
13.11.2 Gilead Sciences Oncology Therapeutic Drug Product Offered
13.11.3 Gilead Sciences Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Gilead Sciences Main Business Overview
13.11.5 Gilead Sciences Latest Developments
13.12 Ipsen
13.12.1 Ipsen Company Information
13.12.2 Ipsen Oncology Therapeutic Drug Product Offered
13.12.3 Ipsen Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Ipsen Main Business Overview
13.12.5 Ipsen Latest Developments
13.13 Johnson and Johnson
13.13.1 Johnson and Johnson Company Information
13.13.2 Johnson and Johnson Oncology Therapeutic Drug Product Offered
13.13.3 Johnson and Johnson Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Johnson and Johnson Main Business Overview
13.13.5 Johnson and Johnson Latest Developments
13.14 Merck
13.14.1 Merck Company Information
13.14.2 Merck Oncology Therapeutic Drug Product Offered
13.14.3 Merck Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Merck Main Business Overview
13.14.5 Merck Latest Developments
13.15 Novartis
13.15.1 Novartis Company Information
13.15.2 Novartis Oncology Therapeutic Drug Product Offered
13.15.3 Novartis Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Novartis Main Business Overview
13.15.5 Novartis Latest Developments
13.16 Otsuka Pharmaceutical
13.16.1 Otsuka Pharmaceutical Company Information
13.16.2 Otsuka Pharmaceutical Oncology Therapeutic Drug Product Offered
13.16.3 Otsuka Pharmaceutical Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Otsuka Pharmaceutical Main Business Overview
13.16.5 Otsuka Pharmaceutical Latest Developments
13.17 Pfizer
13.17.1 Pfizer Company Information
13.17.2 Pfizer Oncology Therapeutic Drug Product Offered
13.17.3 Pfizer Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Pfizer Main Business Overview
13.17.5 Pfizer Latest Developments
13.18 F. Hoffmann-La Roche
13.18.1 F. Hoffmann-La Roche Company Information
13.18.2 F. Hoffmann-La Roche Oncology Therapeutic Drug Product Offered
13.18.3 F. Hoffmann-La Roche Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 F. Hoffmann-La Roche Main Business Overview
13.18.5 F. Hoffmann-La Roche Latest Developments
13.19 Sanofi
13.19.1 Sanofi Company Information
13.19.2 Sanofi Oncology Therapeutic Drug Product Offered
13.19.3 Sanofi Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Sanofi Main Business Overview
13.19.5 Sanofi Latest Developments
13.20 Takeda Pharmaceutical
13.20.1 Takeda Pharmaceutical Company Information
13.20.2 Takeda Pharmaceutical Oncology Therapeutic Drug Product Offered
13.20.3 Takeda Pharmaceutical Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Takeda Pharmaceutical Main Business Overview
13.20.5 Takeda Pharmaceutical Latest Developments
13.21 Teva Pharmaceutical Industries
13.21.1 Teva Pharmaceutical Industries Company Information
13.21.2 Teva Pharmaceutical Industries Oncology Therapeutic Drug Product Offered
13.21.3 Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Teva Pharmaceutical Industries Main Business Overview
13.21.5 Teva Pharmaceutical Industries Latest Developments
14 Research Findings and Conclusion
Table 1. Oncology Therapeutic Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oncology Therapeutic Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Chemotherapy
Table 4. Major Players of Targeted Therapy
Table 5. Major Players of Immunotherapy
Table 6. Major Players of Hormonal Therapy
Table 7. Major Players of Others
Table 8. Global Oncology Therapeutic Drug Sales by Type (2017-2022) & (K Units)
Table 9. Global Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)
Table 10. Global Oncology Therapeutic Drug Revenue by Type (2017-2022) & ($ million)
Table 11. Global Oncology Therapeutic Drug Revenue Market Share by Type (2017-2022)
Table 12. Global Oncology Therapeutic Drug Sale Price by Type (2017-2022) & (US$/Unit)
Table 13. Global Oncology Therapeutic Drug Sales by Application (2017-2022) & (K Units)
Table 14. Global Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)
Table 15. Global Oncology Therapeutic Drug Revenue by Application (2017-2022)
Table 16. Global Oncology Therapeutic Drug Revenue Market Share by Application (2017-2022)
Table 17. Global Oncology Therapeutic Drug Sale Price by Application (2017-2022) & (US$/Unit)
Table 18. Global Oncology Therapeutic Drug Sales by Company (2020-2022) & (K Units)
Table 19. Global Oncology Therapeutic Drug Sales Market Share by Company (2020-2022)
Table 20. Global Oncology Therapeutic Drug Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Oncology Therapeutic Drug Revenue Market Share by Company (2020-2022)
Table 22. Global Oncology Therapeutic Drug Sale Price by Company (2020-2022) & (US$/Unit)
Table 23. Key Manufacturers Oncology Therapeutic Drug Producing Area Distribution and Sales Area
Table 24. Players Oncology Therapeutic Drug Products Offered
Table 25. Oncology Therapeutic Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Oncology Therapeutic Drug Sales by Geographic Region (2017-2022) & (K Units)
Table 29. Global Oncology Therapeutic Drug Sales Market Share Geographic Region (2017-2022)
Table 30. Global Oncology Therapeutic Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Oncology Therapeutic Drug Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Oncology Therapeutic Drug Sales by Country/Region (2017-2022) & (K Units)
Table 33. Global Oncology Therapeutic Drug Sales Market Share by Country/Region (2017-2022)
Table 34. Global Oncology Therapeutic Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Oncology Therapeutic Drug Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Oncology Therapeutic Drug Sales by Country (2017-2022) & (K Units)
Table 37. Americas Oncology Therapeutic Drug Sales Market Share by Country (2017-2022)
Table 38. Americas Oncology Therapeutic Drug Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Oncology Therapeutic Drug Revenue Market Share by Country (2017-2022)
Table 40. Americas Oncology Therapeutic Drug Sales by Type (2017-2022) & (K Units)
Table 41. Americas Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)
Table 42. Americas Oncology Therapeutic Drug Sales by Application (2017-2022) & (K Units)
Table 43. Americas Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)
Table 44. APAC Oncology Therapeutic Drug Sales by Region (2017-2022) & (K Units)
Table 45. APAC Oncology Therapeutic Drug Sales Market Share by Region (2017-2022)
Table 46. APAC Oncology Therapeutic Drug Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Oncology Therapeutic Drug Revenue Market Share by Region (2017-2022)
Table 48. APAC Oncology Therapeutic Drug Sales by Type (2017-2022) & (K Units)
Table 49. APAC Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)
Table 50. APAC Oncology Therapeutic Drug Sales by Application (2017-2022) & (K Units)
Table 51. APAC Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)
Table 52. Europe Oncology Therapeutic Drug Sales by Country (2017-2022) & (K Units)
Table 53. Europe Oncology Therapeutic Drug Sales Market Share by Country (2017-2022)
Table 54. Europe Oncology Therapeutic Drug Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Oncology Therapeutic Drug Revenue Market Share by Country (2017-2022)
Table 56. Europe Oncology Therapeutic Drug Sales by Type (2017-2022) & (K Units)
Table 57. Europe Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)
Table 58. Europe Oncology Therapeutic Drug Sales by Application (2017-2022) & (K Units)
Table 59. Europe Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Oncology Therapeutic Drug Sales by Country (2017-2022) & (K Units)
Table 61. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Oncology Therapeutic Drug Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Oncology Therapeutic Drug Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Oncology Therapeutic Drug Sales by Type (2017-2022) & (K Units)
Table 65. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Oncology Therapeutic Drug Sales by Application (2017-2022) & (K Units)
Table 67. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Oncology Therapeutic Drug
Table 69. Key Market Challenges & Risks of Oncology Therapeutic Drug
Table 70. Key Industry Trends of Oncology Therapeutic Drug
Table 71. Oncology Therapeutic Drug Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Oncology Therapeutic Drug Distributors List
Table 74. Oncology Therapeutic Drug Customer List
Table 75. Global Oncology Therapeutic Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 76. Global Oncology Therapeutic Drug Sales Market Forecast by Region
Table 77. Global Oncology Therapeutic Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Oncology Therapeutic Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 80. Americas Oncology Therapeutic Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Oncology Therapeutic Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 82. APAC Oncology Therapeutic Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Oncology Therapeutic Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Europe Oncology Therapeutic Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Oncology Therapeutic Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Middle East & Africa Oncology Therapeutic Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Oncology Therapeutic Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 88. Global Oncology Therapeutic Drug Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Oncology Therapeutic Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Oncology Therapeutic Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 92. Global Oncology Therapeutic Drug Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Oncology Therapeutic Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Oncology Therapeutic Drug Revenue Market Share Forecast by Application (2023-2028)
Table 95. AbbVie Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. AbbVie Oncology Therapeutic Drug Product Offered
Table 97. AbbVie Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 98. AbbVie Main Business
Table 99. AbbVie Latest Developments
Table 100. Amgen Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Amgen Oncology Therapeutic Drug Product Offered
Table 102. Amgen Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 103. Amgen Main Business
Table 104. Amgen Latest Developments
Table 105. Astellas Pharma Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Astellas Pharma Oncology Therapeutic Drug Product Offered
Table 107. Astellas Pharma Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 108. Astellas Pharma Main Business
Table 109. Astellas Pharma Latest Developments
Table 110. AstraZeneca Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. AstraZeneca Oncology Therapeutic Drug Product Offered
Table 112. AstraZeneca Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 113. AstraZeneca Main Business
Table 114. AstraZeneca Latest Developments
Table 115. Bayer Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Bayer Oncology Therapeutic Drug Product Offered
Table 117. Bayer Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 118. Bayer Main Business
Table 119. Bayer Latest Developments
Table 120. Biogen Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. Biogen Oncology Therapeutic Drug Product Offered
Table 122. Biogen Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 123. Biogen Main Business
Table 124. Biogen Latest Developments
Table 125. Bristol Myers Squibb Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. Bristol Myers Squibb Oncology Therapeutic Drug Product Offered
Table 127. Bristol Myers Squibb Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 128. Bristol Myers Squibb Main Business
Table 129. Bristol Myers Squibb Latest Developments
Table 130. Celgene Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. Celgene Oncology Therapeutic Drug Product Offered
Table 132. Celgene Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 133. Celgene Main Business
Table 134. Celgene Latest Developments
Table 135. Eisai Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. Eisai Oncology Therapeutic Drug Product Offered
Table 137. Eisai Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 138. Eisai Main Business
Table 139. Eisai Latest Developments
Table 140. Eli Lilly and Company Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 141. Eli Lilly and Company Oncology Therapeutic Drug Product Offered
Table 142. Eli Lilly and Company Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 143. Eli Lilly and Company Main Business
Table 144. Eli Lilly and Company Latest Developments
Table 145. Gilead Sciences Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 146. Gilead Sciences Oncology Therapeutic Drug Product Offered
Table 147. Gilead Sciences Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 148. Gilead Sciences Main Business
Table 149. Gilead Sciences Latest Developments
Table 150. Ipsen Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 151. Ipsen Oncology Therapeutic Drug Product Offered
Table 152. Ipsen Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 153. Ipsen Main Business
Table 154. Ipsen Latest Developments
Table 155. Johnson and Johnson Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 156. Johnson and Johnson Oncology Therapeutic Drug Product Offered
Table 157. Johnson and Johnson Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 158. Johnson and Johnson Main Business
Table 159. Johnson and Johnson Latest Developments
Table 160. Merck Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 161. Merck Oncology Therapeutic Drug Product Offered
Table 162. Merck Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 163. Merck Main Business
Table 164. Merck Latest Developments
Table 165. Novartis Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 166. Novartis Oncology Therapeutic Drug Product Offered
Table 167. Novartis Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 168. Novartis Main Business
Table 169. Novartis Latest Developments
Table 170. Otsuka Pharmaceutical Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 171. Otsuka Pharmaceutical Oncology Therapeutic Drug Product Offered
Table 172. Otsuka Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 173. Otsuka Pharmaceutical Main Business
Table 174. Otsuka Pharmaceutical Latest Developments
Table 175. Pfizer Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 176. Pfizer Oncology Therapeutic Drug Product Offered
Table 177. Pfizer Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 178. Pfizer Main Business
Table 179. Pfizer Latest Developments
Table 180. F. Hoffmann-La Roche Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 181. F. Hoffmann-La Roche Oncology Therapeutic Drug Product Offered
Table 182. F. Hoffmann-La Roche Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 183. F. Hoffmann-La Roche Main Business
Table 184. F. Hoffmann-La Roche Latest Developments
Table 185. Sanofi Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 186. Sanofi Oncology Therapeutic Drug Product Offered
Table 187. Sanofi Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 188. Sanofi Main Business
Table 189. Sanofi Latest Developments
Table 190. Takeda Pharmaceutical Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 191. Takeda Pharmaceutical Oncology Therapeutic Drug Product Offered
Table 192. Takeda Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 193. Takeda Pharmaceutical Main Business
Table 194. Takeda Pharmaceutical Latest Developments
Table 195. Teva Pharmaceutical Industries Basic Information, Oncology Therapeutic Drug Manufacturing Base, Sales Area and Its Competitors
Table 196. Teva Pharmaceutical Industries Oncology Therapeutic Drug Product Offered
Table 197. Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 198. Teva Pharmaceutical Industries Main Business
Table 199. Teva Pharmaceutical Industries Latest Developments
List of Figures
Figure 1. Picture of Oncology Therapeutic Drug
Figure 2. Oncology Therapeutic Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oncology Therapeutic Drug Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Oncology Therapeutic Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oncology Therapeutic Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Chemotherapy
Figure 10. Product Picture of Targeted Therapy
Figure 11. Product Picture of Immunotherapy
Figure 12. Product Picture of Hormonal Therapy
Figure 13. Product Picture of Others
Figure 14. Global Oncology Therapeutic Drug Sales Market Share by Type in 2021
Figure 15. Global Oncology Therapeutic Drug Revenue Market Share by Type (2017-2022)
Figure 16. Oncology Therapeutic Drug Consumed in Breast Cancer
Figure 17. Global Oncology Therapeutic Drug Market: Breast Cancer (2017-2022) & (K Units)
Figure 18. Oncology Therapeutic Drug Consumed in Gastrointestinal Cancer
Figure 19. Global Oncology Therapeutic Drug Market: Gastrointestinal Cancer (2017-2022) & (K Units)
Figure 20. Oncology Therapeutic Drug Consumed in Prostate Cancer
Figure 21. Global Oncology Therapeutic Drug Market: Prostate Cancer (2017-2022) & (K Units)
Figure 22. Oncology Therapeutic Drug Consumed in Respiratory and Lung Cancer
Figure 23. Global Oncology Therapeutic Drug Market: Respiratory and Lung Cancer (2017-2022) & (K Units)
Figure 24. Oncology Therapeutic Drug Consumed in Others
Figure 25. Global Oncology Therapeutic Drug Market: Others (2017-2022) & (K Units)
Figure 26. Global Oncology Therapeutic Drug Sales Market Share by Application (2017-2022)
Figure 27. Global Oncology Therapeutic Drug Revenue Market Share by Application in 2021
Figure 28. Oncology Therapeutic Drug Revenue Market by Company in 2021 ($ Million)
Figure 29. Global Oncology Therapeutic Drug Revenue Market Share by Company in 2021
Figure 30. Global Oncology Therapeutic Drug Sales Market Share by Geographic Region (2017-2022)
Figure 31. Global Oncology Therapeutic Drug Revenue Market Share by Geographic Region in 2021
Figure 32. Global Oncology Therapeutic Drug Sales Market Share by Region (2017-2022)
Figure 33. Global Oncology Therapeutic Drug Revenue Market Share by Country/Region in 2021
Figure 34. Americas Oncology Therapeutic Drug Sales 2017-2022 (K Units)
Figure 35. Americas Oncology Therapeutic Drug Revenue 2017-2022 ($ Millions)
Figure 36. APAC Oncology Therapeutic Drug Sales 2017-2022 (K Units)
Figure 37. APAC Oncology Therapeutic Drug Revenue 2017-2022 ($ Millions)
Figure 38. Europe Oncology Therapeutic Drug Sales 2017-2022 (K Units)
Figure 39. Europe Oncology Therapeutic Drug Revenue 2017-2022 ($ Millions)
Figure 40. Middle East & Africa Oncology Therapeutic Drug Sales 2017-2022 (K Units)
Figure 41. Middle East & Africa Oncology Therapeutic Drug Revenue 2017-2022 ($ Millions)
Figure 42. Americas Oncology Therapeutic Drug Sales Market Share by Country in 2021
Figure 43. Americas Oncology Therapeutic Drug Revenue Market Share by Country in 2021
Figure 44. United States Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. Canada Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. Mexico Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. Brazil Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. APAC Oncology Therapeutic Drug Sales Market Share by Region in 2021
Figure 49. APAC Oncology Therapeutic Drug Revenue Market Share by Regions in 2021
Figure 50. China Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Japan Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. South Korea Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Southeast Asia Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. India Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. Australia Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Europe Oncology Therapeutic Drug Sales Market Share by Country in 2021
Figure 57. Europe Oncology Therapeutic Drug Revenue Market Share by Country in 2021
Figure 58. Germany Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. France Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. UK Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Italy Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. Russia Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Middle East & Africa Oncology Therapeutic Drug Sales Market Share by Country in 2021
Figure 64. Middle East & Africa Oncology Therapeutic Drug Revenue Market Share by Country in 2021
Figure 65. Egypt Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. South Africa Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 67. Israel Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 68. Turkey Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 69. GCC Country Oncology Therapeutic Drug Revenue Growth 2017-2022 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Oncology Therapeutic Drug in 2021
Figure 71. Manufacturing Process Analysis of Oncology Therapeutic Drug
Figure 72. Industry Chain Structure of Oncology Therapeutic Drug
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...